Lung Cancer Flashcards
Histology of non-small cell lung cancer (~80%)
Adenocarcinoma (around 40%)
Squamous cell carcinoma (around 20%)
Large-cell carcinoma (around 10%)
Other types (around 10%)
Histology of small cell lung cancer (~20%)
Cells contain neurosecretory granules that can release neuroendocrine hormones
This makes SCLC responsible for multiple paraneoplastic syndromes
Signs and symptoms of lung cancer
Shortness of breath
Cough
Haemoptysis
Finger clubbing
Recurrent pneumonia
Weight loss
Lymphadenopathy – often supraclavicular nodes are the first to be found on examination
CXR findings in lung cancer
Hilar enlargement
“Peripheral opacity” – a visible lesion in the lung field
Pleural effusion – usually unilateral in cancer
Collapse
Investigations in lung cancer
CXR
Staging CT (contrast enhanced)
PET-CT (using radioactive tracer)
Bronchoscopy
Histological diagnosis
Management of non-small cell lung cancer
Non-small cell lung cancer:
Surgery first line
Radiotherapy can be curative
Chemotherapy as adjuvant therapy
Management of small cell lung cancer
Chemotherapy + radiotherapy
Palliative treatment in lung cancer
Endobronchial treatment with stents/debulking
Chemotherapy
Extrapulmonary manifestations in lung cancer
Recurrent laryngeal nerve palsy (hoarse voice)
Phrenic nerve palsy (SOB)
SVC obstruction
Horner’s syndrome
SIADH
Cushing’s syndrome
Hypercalcaemia
Limbic encephalitis
Lambert-Easton myasthenic syndrome
Lamber-Easton myasthenic syndrome
Antibodies produced against small cell lung cancer cells
These antibodies also target and damage voltage-gated calcium channels sited on the presynaptic terminals in motor neurones leading to weakness
Symptoms of Lambert-Easton syndrome
Weakness in proximal muscles
Weakness in intraocular muscles (diplopia)
Weakness in levator muscles (ptosis)
Weakness in pharyngeal muscles (slurred speech, dysphagia)
Dry mouth, impotence and dizziness due to autonomic dysfunction
What to consider in older patients with symptoms of Lambert-Easton syndrome
Small cell lung cancer
What is mesothelioma?
Lung malignancy affecting the mesothelial cells of the pleura
Strongly linked to asbestos inhalation
Huge latent period between exposure to asbestos and development of mesothelioma (up to 45 years)